Bitcoin tumbles as U.S. senators grill Facebook on crypto plans
The cryptocurrency market took a beating on Tuesday with bitcoin losing over 10% in value after U.S. lawmakers grilled Facebook on its cryptocurrency plans, as...
Blue Apron beefs up menu with Beyond Meat, shares surge 60%
Blue Apron Holdings Inc’s beleaguered stock surged 60% on Tuesday after the meal-kit subscription service said it would add Beyond Meat Inc’s plant-based burgers to...
Global stocks fall, U.S. yields rise on retail sales data
A gauge of global equities fell on Tuesday and U.S. Treasury yields climbed as a stronger-than-anticipated report on retail sales raised the possibility the Federal...
JPMorgan beats profit estimates but shows signs of pressure
JPMorgan Chase & Co reported a quarterly profit that beat estimates on Tuesday as higher interest income and consumer lending offset lower activity at its...
Five things to look for in Netflix’s second-quarter report
When Netflix Inc reports second-quarter earnings on Wednesday, a big question is how the streaming giant will handle a slew of new competitors barging in...
Wells Fargo tempers cost-cutting outlook
Wells Fargo & Co reported higher quarterly earnings on Tuesday, due in part to lower expenses, but the bank reined in its outlook for cost...
Wall Street edges lower after mixed bank earnings, Trump comments
U.S. stocks were lower on Tuesday as results from big Wall Street lenders rekindled concerns about slowing profit growth in a low interest rate environment,...
UAW president to GM: We invested in you, now invest in us
The UAW and General Motors Co on Tuesday formally kicked off contract talks, with the union’s president calling on the automaker to keep open plants...
Bitcoin falls below $10,000 after Facebook grilled on crypto plans
Bitcoin fell 8% on Tuesday, breaching $10,000 for the first time in two weeks after U.S. lawmakers grilled Facebook on its cryptocurrency plans, as political...
J&J warns of hit from generic drugs in third quarter, shares fall
Johnson & Johnson on Tuesday boosted its 2019 sales forecast amid robust demand for its cancer drugs, but warned that competition from generic and copycat...